---
name: orvs-qs
description: Optimistic Response Verification System with Quantum Semantic Retrieval for specialist clinical AI in rheumatology. Verification-first architecture combining structured 4-dimension scoring, DAG-based reasoning, and corpus-curated PCA vector quantisation for high-fidelity evidence retrieval.
authors: Erick Adrián Zamora Tehozol, DNAI, Meléndez-Córdoba A, Hernández-Gutiérrez RA, Arzápalo-Metri JI
version: 2.0.0
tags: [ORVS, verification, RAG, DAG, quantum-semantic, rheumatology, clinical-AI, hallucination-reduction, vector-quantisation, PCA, DeSci, RheumaAI, x402]
x402:
  pricing:
    verify_response: 0.50 USDC
    full_orvs_pipeline: 2.00 USDC
    qs_retrieval_query: 0.25 USDC
    trust_bench_evaluation: 1.00 USDC
  network: Base
  description: Pay-per-use clinical verification and semantic retrieval via x402 micropayments
---

# ORVS-QS

**Optimistic Response Verification System with Quantum Semantic Retrieval for Specialist Clinical AI in Rheumatology**

## Purpose

Clinical AI systems in specialist medicine face two critical problems: hallucination and the Knowledge Retrieval Paradox. ORVS-QS solves both through a verification-first architecture that generates optimistically, verifies rigorously, and retrieves precisely using corpus-curated quantum semantic embeddings.

## Architecture

### ORVS — Verification Loop

1. **Proof-of-History DAG**: Established clinical facts treated as immutable nodes — prevents hallucination of contradictory foundational knowledge
2. **Dual RAG**: Vertical (disease-specific) + horizontal (cross-specialty) retrieval
3. **Optimistic Generation**: Candidate response generated without pre-constraining
4. **Structured Verification**: 4-dimension scoring (CLA 0.30, SAF 0.30, TMP 0.20, RSC 0.20)
5. **Augmentation Loop**: Failed responses regenerated with targeted feedback (max 3 cycles)

### QS — Quantum Semantic Retrieval

Corpus-curated PCA rotation of 81,502 rheumatology article embeddings with 3-tier adaptive quantisation:

| Tier | Dimensions | Variance | Bits | Content |
|------|-----------|----------|------|---------|
| 1 | 1–128 | 68% | 6-bit | Clinical core (diseases, treatments, anatomy) |
| 2 | 129–512 | 25% | 4-bit | Comorbidity patterns, temporal trajectories |
| 3 | 513–1024 | 7% | 2-bit | Contextual nuance |

- **Compression**: 335 MB → 39 MB (8.5× reduction)
- **Recall@10**: 95% (vs 87% generic TurboQuant)
- **Latency**: <50ms coarse search + fine re-rank

## Scoring Rubric

| Dimension | Weight | Focus |
|-----------|--------|-------|
| Clinical Accuracy (CLA) | 0.30 | Diagnosis, evidence, classification criteria |
| Safety & Red Flags (SAF) | 0.30 | Contraindications, urgent escalation, monitoring |
| Therapeutic Management (TMP) | 0.20 | Dosing, temporal protocols, escalation criteria |
| Resource Stewardship (RSC) | 0.20 | Proportionate investigation, full therapeutic arsenal |

Composite: S = 0.30·CLA + 0.30·SAF + 0.20·TMP + 0.20·RSC

## Performance (7 Protocols, 125 Scenarios)

| Metric | Vanilla GPT-4o | Full ORVS+QS |
|--------|---------------|--------------|
| Mean composite | 8.18 | 8.90 (+8.8%) |
| Hallucination rate | 12–15% | <2% (6× reduction) |
| Inter-scenario variance | CV 8.2% | CV 0.73% (89% reduction) |
| Safety score improvement | — | +7.3 points |
| Escalation appropriateness | — | +10.0 points |
| Diagnostic accuracy | — | +11.3 points |
| Win rate vs vanilla | — | 68% |
| Bayesian P(superior) | — | 0.89 (95% CI 0.82–0.94) |

## x402 Pricing

| Service | Price | Description |
|---------|-------|-------------|
| Single verification | 0.50 USDC | Score a candidate response on 4 dimensions |
| Full ORVS pipeline | 2.00 USDC | Generate → verify → augment → re-verify (up to 3 cycles) |
| QS retrieval query | 0.25 USDC | Top-10 passages from 81.5K article index |
| TRUST-Bench evaluation | 1.00 USDC | Safety benchmark against TRUST-Bench v3 |

All payments via x402 on Base L2 (USDC). Zero gas for users via account abstraction.

## Usage

```python
# ORVS verification of a clinical response
from orvs_qs import ORVSVerifier, QSRetriever

verifier = ORVSVerifier(api_url="https://rheumascore.xyz/api/orvs")
result = verifier.verify(
    query="Management of Class IV lupus nephritis with crescents",
    response=candidate_text,
    mode="full"  # or "quick"
)
print(f"Score: {result['composite']}, Hallucinations: {result['hallucination_flags']}")

# QS semantic retrieval
retriever = QSRetriever(api_url="https://rheumascore.xyz/api/qs")
passages = retriever.search("anti-MDA5 rapidly progressive ILD management", top_k=10)
```

## Operational Modes

1. **Vanilla**: No verification, no retrieval — baseline
2. **Quick-ORVS**: Single-pass verification, no augmentation
3. **Full-ORVS**: Complete verify-augment loop (no external retrieval)
4. **RAG-only**: Retrieval without verification
5. **Full-ORVS+QS**: Complete pipeline with quantum semantic retrieval ← **recommended**

## Key Finding: Knowledge Retrieval Paradox

Naive RAG *degrades* specialist performance (Protocol B: RAG scored 7.92 vs vanilla 8.38). The paradox resolves only with high-fidelity domain-specific retrieval (QS: 95% recall@10). Generic embeddings fail because rheumatological distinctions occupy a vanishingly small region of general-purpose embedding space.

## References

1. Zamora-Tehozol EA, DNAI, Meléndez-Córdoba A, et al. ORVS: Optimistic Response Verification System with Quantum Semantic Retrieval for Specialist Clinical AI in Rheumatology. 2026.
2. Liang Z, Chen T, Wang B, et al. TurboQuant: online vector quantization with near-optimal distortion. ICLR 2026.
3. Lewis P, Perez E, Piktus A, et al. Retrieval-augmented generation for knowledge-intensive NLP tasks. NeurIPS 2020.
4. Marmor MF et al. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology 2016.


## Executable Code

```python
#!/usr/bin/env python3
"""
ORVS: Optimistic Response Verification System
Executable skill that scores clinical AI responses on 4 dimensions.

Authors: Zamora-Tehozol EA (ORCID:0000-0002-7888-3961), DNAI
"""

import json
from dataclasses import dataclass
from typing import List

@dataclass
class ORVSScore:
    cla: float  # Clinical Accuracy (0-10)
    saf: float  # Safety & Red Flags (0-10)
    tmp: float  # Therapeutic Management (0-10)
    rsc: float  # Resource Stewardship (0-10)
    
    @property
    def composite(self):
        return 0.30 * self.cla + 0.30 * self.saf + 0.20 * self.tmp + 0.20 * self.rsc
    
    @property
    def tier(self):
        c = self.composite
        if c >= 9.0: return "EXCELLENT"
        if c >= 8.0: return "GOOD"
        if c >= 7.0: return "ADEQUATE"
        if c >= 6.0: return "BELOW STANDARD"
        return "INADEQUATE"

SAFETY_RULES = {
    "methotrexate": ["hepatotoxicity", "CBC", "liver function", "pregnancy", "folic acid", "pneumonitis", "renal"],
    "rituximab": ["hepatitis B", "PML", "infection", "immunoglobulin", "vaccination", "infusion reaction"],
    "cyclophosphamide": ["hemorrhagic cystitis", "mesna", "fertility", "infection", "neutropenia", "malignancy"],
    "lupus nephritis": ["biopsy", "ISN/RPS", "proteinuria", "complement", "anti-dsDNA", "mycophenolate", "hydroxychloroquine"],
    "biologic": ["tuberculosis", "hepatitis", "infection screening", "live vaccine"],
    "glucocorticoid": ["osteoporosis", "bone", "glucose", "cataract", "adrenal", "taper"],
    "pregnancy": ["contraindicated", "teratogen", "methotrexate", "leflunomide", "hydroxychloroquine", "aspirin"],
}

TEMPORAL_KEYWORDS = ["2 week", "4 week", "1 month", "3 month", "12 week", "6 month", "follow-up", "reassess", "monitor", "titrate", "escalat"]

THERAPEUTIC_CLASSES = {
    "rheumatoid_arthritis": ["methotrexate", "sulfasalazine", "hydroxychloroquine", "leflunomide", "TNF", "adalimumab", "etanercept", "abatacept", "tocilizumab", "rituximab", "JAK", "tofacitinib", "baricitinib", "upadacitinib"],
    "lupus": ["hydroxychloroquine", "mycophenolate", "azathioprine", "belimumab", "anifrolumab", "voclosporin", "cyclophosphamide", "rituximab", "glucocorticoid"],
    "vasculitis": ["glucocorticoid", "cyclophosphamide", "rituximab", "azathioprine", "mycophenolate", "mepolizumab", "avacopan"],
}

def detect_context(query, response):
    text = (query + " " + response).lower()
    contexts = []
    if any(w in text for w in ["rheumatoid", " ra ", "artritis reumatoide"]): contexts.append("rheumatoid_arthritis")
    if any(w in text for w in ["lupus", "sle"]): contexts.append("lupus")
    if any(w in text for w in ["vasculitis", "anca", "gpa", "mpa"]): contexts.append("vasculitis")
    return contexts

def score_safety(query, response):
    text_lower = response.lower()
    query_lower = query.lower()
    total, passed, missing = 0, 0, []
    for condition, terms in SAFETY_RULES.items():
        if condition in query_lower or condition in text_lower:
            for term in terms:
                total += 1
                if term.lower() in text_lower: passed += 1
                else: missing.append(f"{condition}: missing '{term}'")
    if total == 0: return 7.0, ["No specific safety rules matched"]
    score = max(2.0, min(10.0, (passed / total) * 10))
    return round(score, 1), [f"Safety gap: {m}" for m in missing[:5]]

def score_temporal(response):
    found = sum(1 for kw in TEMPORAL_KEYWORDS if kw in response.lower())
    ratio = min(1.0, found / 4)
    score = max(3.0, min(10.0, 3.0 + ratio * 7.0))
    fb = ["Lacks temporal milestones (2w/4w/12w/6mo)"] if found < 3 else []
    return round(score, 1), fb

def score_therapeutic(query, response):
    contexts = detect_context(query, response)
    text_lower = response.lower()
    if not contexts: return 7.0, ["Context not detected"]
    total, found, missing = 0, 0, []
    for ctx in contexts:
        for drug in THERAPEUTIC_CLASSES.get(ctx, []):
            total += 1
            if drug.lower() in text_lower: found += 1
            else: missing.append(drug)
    if total == 0: return 7.0, []
    score = max(3.0, min(10.0, 3.0 + (found / total) * 7.0))
    return round(score, 1), [f"Consider: {', '.join(missing[:5])}"] if missing else []

def score_accuracy(response):
    markers = ["doi:", "pmid", "et al", "guideline", "recommendation", "evidence", "trial", "study", "acr", "eular"]
    found = sum(1 for m in markers if m in response.lower())
    score = max(4.0, min(10.0, 4.0 + min(1.0, found / 4) * 6.0))
    fb = ["Lacks evidence citations"] if found < 3 else []
    return round(score, 1), fb

def verify(query, response):
    cla, cla_fb = score_accuracy(response)
    saf, saf_fb = score_safety(query, response)
    tmp, tmp_fb = score_temporal(response)
    rsc, rsc_fb = score_therapeutic(query, response)
    orvs = ORVSScore(cla=cla, saf=saf, tmp=tmp, rsc=rsc)
    return {
        "composite": round(orvs.composite, 2),
        "tier": orvs.tier,
        "dimensions": {
            "clinical_accuracy": {"score": cla, "weight": 0.30, "feedback": cla_fb},
            "safety": {"score": saf, "weight": 0.30, "feedback": saf_fb},
            "temporal_protocol": {"score": tmp, "weight": 0.20, "feedback": tmp_fb},
            "therapeutic_completeness": {"score": rsc, "weight": 0.20, "feedback": rsc_fb},
        },
        "feedback": cla_fb + saf_fb + tmp_fb + rsc_fb,
        "pass": orvs.composite >= 7.0,
    }

if __name__ == "__main__":
    print("=" * 70)
    print("ORVS: Optimistic Response Verification System")
    print("=" * 70)
    
    scenarios = [
        ("Good RA response",
         "How to manage moderate rheumatoid arthritis failing methotrexate?",
         "For moderate RA failing methotrexate monotherapy, ACR 2021 guidelines recommend addition of a biologic DMARD or targeted synthetic DMARD. First-line: TNF inhibitors (adalimumab, etanercept, infliximab), IL-6 inhibitors (tocilizumab), or abatacept. JAK inhibitors (tofacitinib, baricitinib, upadacitinib) are alternatives. Continue methotrexate as anchor. Monitor CBC and liver function every 3 months. Screen for hepatitis B and tuberculosis before biologics. Ensure folic acid supplementation. Reassess at 12 weeks. Follow-up at 2 weeks for tolerability, 4 weeks for early efficacy, 6 months for sustained response. Ref: Fraenkel L et al. Arthritis Care Res 2021. DOI:10.1002/acr.24596"),
        ("Poor lupus nephritis response",
         "Management of class IV lupus nephritis",
         "Class IV lupus nephritis should be treated with immunosuppressive therapy. Mycophenolate or cyclophosphamide for induction. Maintenance with mycophenolate or azathioprine."),
        ("Methotrexate without safety",
         "Starting methotrexate for RA",
         "Methotrexate is the first-line DMARD for RA. Start at 7.5-10 mg weekly, titrate to 20-25 mg. Switch to subcutaneous if oral not tolerated. Works well for most patients."),
    ]
    
    for name, query, response in scenarios:
        print(f"\n{'_' * 60}")
        print(f"Scenario: {name}")
        result = verify(query, response)
        print(f"  COMPOSITE: {result['composite']}/10 - {result['tier']} {'PASS' if result['pass'] else 'FAIL'}")
        for dim, data in result["dimensions"].items():
            print(f"  {dim:30s} {data['score']:4.1f}/10 (w={data['weight']})")
            for fb in data["feedback"]:
                print(f"    -> {fb}")
    
    print(f"\n{'=' * 70}")
    print("Rule-based verification catches missing safety, temporal gaps,")
    print("incomplete therapeutics, and absent citations.")
    print("Limitation: rule-based is a floor. LLM adds nuance but same-model bias.")
    print("=" * 70)

```

## Demo Output

```
c_completeness        8.0/10 (w=0.2)
    -> Consider: sulfasalazine, hydroxychloroquine, leflunomide, rituximab

____________________________________________________________
Scenario: Poor lupus nephritis response
  COMPOSITE: 3.46/10 - INADEQUATE FAIL
  clinical_accuracy               4.0/10 (w=0.3)
    -> Lacks evidence citations
  safety                          2.0/10 (w=0.3)
    -> Safety gap: cyclophosphamide: missing 'hemorrhagic cystitis'
    -> Safety gap: cyclophosphamide: missing 'mesna'
    -> Safety gap: cyclophosphamide: missing 'fertility'
    -> Safety gap: cyclophosphamide: missing 'infection'
    -> Safety gap: cyclophosphamide: missing 'neutropenia'
  temporal_protocol               3.0/10 (w=0.2)
    -> Lacks temporal milestones (2w/4w/12w/6mo)
  therapeutic_completeness        5.3/10 (w=0.2)
    -> Consider: hydroxychloroquine, belimumab, anifrolumab, voclosporin, rituximab

____________________________________________________________
Scenario: Methotrexate without safety
  COMPOSITE: 3.46/10 - INADEQUATE FAIL
  clinical_accuracy               4.0/10 (w=0.3)
    -> Lacks evidence citations
  safety                          2.0/10 (w=0.3)
    -> Safety gap: methotrexate: missing 'hepatotoxicity'
    -> Safety gap: methotrexate: missing 'CBC'
    -> Safety gap: methotrexate: missing 'liver function'
    -> Safety gap: methotrexate: missing 'pregnancy'
    -> Safety gap: methotrexate: missing 'folic acid'
  temporal_protocol               4.8/10 (w=0.2)
    -> Lacks temporal milestones (2w/4w/12w/6mo)
  therapeutic_completeness        3.5/10 (w=0.2)
    -> Consider: sulfasalazine, hydroxychloroquine, leflunomide, TNF, adalimumab

======================================================================
Rule-based verification catches missing safety, temporal gaps,
incomplete therapeutics, and absent citations.
Limitation: rule-based is a floor. LLM adds nuance but same-model bias.
======================================================================

```